60481-35-8 Usage
Uses
Used in Organic Synthesis:
(2-BROMO-5-FLUOROPHENYL)HYDRAZINEHYDROCHLORIDE is used as a building block for the synthesis of various organic compounds, providing a foundation for the creation of new molecules with specific properties and applications.
Used in Pharmaceutical Intermediates:
In the pharmaceutical industry, (2-BROMO-5-FLUOROPHENYL)HYDRAZINEHYDROCHLORIDE is utilized as a key intermediate in the development of new drugs. Its unique structure allows for the design of molecules with targeted therapeutic effects.
Used in Medicinal Chemistry:
(2-BROMO-5-FLUOROPHENYL)HYDRAZINEHYDROCHLORIDE is employed as a research tool in medicinal chemistry, aiding scientists in understanding the interactions between molecules and their biological targets, which is essential for the development of effective treatments.
Used in Biochemistry:
(2-BROMO-5-FLUOROPHENYL)HYDRAZINEHYDROCHLORIDE also finds use in biochemistry, where it can be involved in studies of enzyme mechanisms, protein interactions, and other biological processes, contributing to a deeper understanding of life sciences.
Check Digit Verification of cas no
The CAS Registry Mumber 60481-35-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,4,8 and 1 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 60481-35:
(7*6)+(6*0)+(5*4)+(4*8)+(3*1)+(2*3)+(1*5)=108
108 % 10 = 8
So 60481-35-8 is a valid CAS Registry Number.
60481-35-8Relevant academic research and scientific papers
HIV integrase inhibitors
-
Page/Page column 22, (2010/11/27)
The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV.
Substituted tetrahydro-1H-pyrido[4,3-b]indoles as serotonin receptors agonists and antagonists
-
Page/Page column 21, (2010/11/25)
The present application describes compounds, including all pharmaceutically acceptable salts, prodrugs, solvates and stereoisomers thereof, according to Formula I, pharmaceutical compositions, comprising at least one compound according to Formula I and optionally at least one additional therapeutic agent and methods of treating various diseases, conditions and disorders associated with modulation of serotonin receptors such as, for example: metabolic diseases, which includes but is not limited to obesity, diabetes, diabetic complications, atherosclerosis, impared glucose tolerance and dyslipidemia; central nervous system diseases which includes but is not limited to, anxiety, depression, obsessive compulsive disorder, panic disorder, psychosis, schizophrenia, sleep disorder, sexual disorder and social phobias; cephalic pain; migraine; and gastrointestinal disorders using compounds according to Formula I
